shim
Abbott A Annual Report 2006 signature
Page 20 of 40
Financials Arrow Prev Previous Next Arrow Next
shim

Consolidated Balance Sheet

(dollars in thousands)

December 31   2006     2005     2004  
Assets                  
Current Assets:
Cash and cash equivalents		 $ 521,192   $ 2,893,687   $ 1,225,628  
Investments   852,243     62,406     833,334  
Trade receivables, less allowances of —
2006: $215,443; 2005: $203,683; 2004: $231,704		   4,231,142     3,576,794     3,696,115  
Inventories:
Finished products		   1,338,349     1,203,557     1,488,939  
Work in process   686,425     630,267     582,787  
Materials   781,647     708,155     548,737  
Total inventories   2,806,421     2,541,979     2,620,463  
Deferred income taxes   1,716,916     1,248,569     1,031,746  
Other prepaid expenses and receivables   1,153,969     932,691     1,080,143  
Assets held for sale   —     129,902     247,056  
Total Current Assets   11,281,883     11,386,028     10,734,485  

Investments		   1,229,873     134,013     145,849  

Property and Equipment, at Cost:
Land		   488,342     370,949     338,428  
Buildings   3,228,485     2,655,356     2,519,492  
Equipment   9,947,503     8,813,517     8,681,655  
Construction in progress   737,609     920,599     962,114  
    14,401,939     12,760,421     12,501,689  
Less: accumulated depreciation and amortization   7,455,504     6,757,280     6,493,815  
Net Property and Equipment   6,946,435     6,003,141     6,007,874  

Intangible Assets, net of amortization		   6,403,619     4,741,647     5,171,594  
Goodwill   9,449,281     5,219,247     5,685,124  
Deferred Income Taxes and Other Assets   867,081     1,624,201     952,929  
Assets Held for Sale   —     32,926     69,639  
  $ 36,178,172   $ 29,141,203   $ 28,767,494  
December 31   2006     2005     2004  
Liabilities and Shareholders’ Investment                  
Current Liabilities:
Short-term borrowings		 $ 5,305,985   $ 212,447   $ 1,836,649  
Trade accounts payable   1,175,590     1,032,516     1,054,464  
Salaries, wages and commissions   807,283     625,254     637,333  
Other accrued liabilities   3,850,723     2,722,685     2,491,956  
Dividends payable   453,994     423,335     405,730  
Income taxes payable   262,344     488,926     156,417  
Current portion of long-term debt   95,276     1,849,563     156,034  
Liabilities of operations held for sale   —     60,788     87,061  
Total Current Liabilities   11,951,195     7,415,514     6,825,644  
Long-term Debt   7,009,664     4,571,504     4,787,934  
Post-employment Obligations and Other Long-term Liabilities   3,163,127     2,154,775     2,606,410  
Liabilities of Operations Held for Sale   —     1,062     1,644  
Deferred Income Taxes   —     583,077     220,079  

Commitments and Contingencies		                  

Shareholders’ Investment:
Preferred shares, one dollar par value
Authorized — 1,000,000 shares, none issued		   —     —     —  
Common shares, without par value
Authorized — 2,400,000,000 shares
Issued at stated capital amount —
Shares: 2006: 1,550,590,438;
2005: 1,553,769,958; 2004: 1,575,147,418		   4,290,929     3,477,460     3,189,465  
Common shares held in treasury, at cost —
Shares: 2006: 13,347,272;
2005: 14,534,979; 2004: 15,123,800		   (195,237 )   (212,255 )   (220,854 )
Earnings employed in the business   9,568,728     10,404,568     10,033,440  
Accumulated other comprehensive income (loss)   389,766     745,498     1,323,732  
Total Shareholders’ Investment   14,054,186     14,415,271     14,325,783  
  $ 36,178,172   $ 29,141,203   $ 28,767,494  

The accompanying notes to consolidated financial statements are an integral part of this statement.
Arrow Top Page Top Arrow Prev Previous Next Arrow Next
shim

| Abbott Home | Contact Us | Privacy Policy | Terms of Use |

© 2007 Abbott Laboratories